Valneva SE (VALN) Inventory (2020 - 2026)
Valneva SE (VALN) posted Inventory of $59.2 million for Q1 2026, up 1.28% sequentially from $58.5 million in Q4 2025, and down 8.72% YoY from $64.9 million in Q1 2025.
Valneva SE (VALN) Inventory (2020 - 2026) Analysis & Trends
Valneva SE has reported Inventory for 7 years, with the latest figure at $59.2 million in Q1 2026.
- Quarterly Inventory fell 8.72% year-over-year to $59.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.2 million (down 8.72% YoY) and the FY2025 annual result came in at $58.5 million, up 0.67% from the prior year.
- Inventory advanced to $59.2 million in Q1 2026 per VALN's latest filing, from $58.5 million in the prior quarter.
- Over five years, Inventory peaked at $156.8 million in Q1 2022 and troughed at $35.8 million in Q4 2022.
- A 5-year average of $65.5 million and a median of $58.5 million in 2025 frame the typical range for Inventory.
- The sharpest annual moves came in 2022 and 2024: Inventory slumped 74.77% in 2022, then soared 53.53% in 2024.
- Over 5 years, Inventory stood at $35.8 million in 2022, then surged by 33.58% to $47.8 million in 2023, then climbed by 19.86% to $57.3 million in 2024, then advanced by 1.97% to $58.5 million in 2025, then gained by 1.28% to $59.2 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $59.2 million, $58.5 million, and $75.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn | 55.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.98 Mn |
| Mar 31, 2026 | 59.22 Mn |
| Dec 31, 2025 | 58.47 Mn |
| Sep 30, 2025 | 75.16 Mn |
| Jun 30, 2025 | 69.88 Mn |
| Mar 31, 2025 | 64.88 Mn |
| Dec 31, 2024 | 57.34 Mn |
| Sep 30, 2024 | 63.51 Mn |
| Jun 30, 2024 | 52.62 Mn |
| Mar 31, 2024 | 52.78 Mn |
| Dec 31, 2023 | 47.84 Mn |
| Sep 30, 2023 | 41.37 Mn |
| Jun 30, 2023 | 36.32 Mn |
| Mar 31, 2023 | 41.86 Mn |
| Dec 31, 2022 | 35.81 Mn |
| Sep 30, 2022 | 97.26 Mn |
| Jun 30, 2022 | 101.58 Mn |
| Mar 31, 2022 | 156.82 Mn |
| Dec 31, 2021 | 141.96 Mn |
| Dec 31, 2020 | 32.11 Mn |